{"id":29944,"date":"2025-02-07T10:47:42","date_gmt":"2025-02-07T15:47:42","guid":{"rendered":"https:\/\/myeloma.ca\/?p=29944"},"modified":"2025-02-07T13:04:20","modified_gmt":"2025-02-07T18:04:20","slug":"long-wait-for-cancer-drug-approvals-causing-great-anguish-among-patients-doctors-la-longue-attente-pour-lapprobation-des-medicaments-anticancereux-provoque-une-grande","status":"publish","type":"post","link":"https:\/\/myeloma.ca\/fr\/2025\/02\/07\/long-wait-for-cancer-drug-approvals-causing-great-anguish-among-patients-doctors-la-longue-attente-pour-lapprobation-des-medicaments-anticancereux-provoque-une-grande\/","title":{"rendered":"\u00ab\u00a0Long wait for cancer drug approvals causing &lsquo;great anguish&rsquo; among patients, doctors\u00bb [La longue attente pour l&rsquo;approbation des m\u00e9dicaments anticanc\u00e9reux provoque une \u00ab grande angoisse \u00bb chez les patients et les m\u00e9decins] &#8211; (en anglais)"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">Des traitements potentiellement vitaux retard\u00e9s par la bureaucratie, selon les m\u00e9decins<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">En avril 2017, Glenn Hussey s&rsquo;est rendu \u00e0 l&rsquo;H\u00f4pital d&rsquo;Ottawa pour un examen r\u00e9gulier afin de surveiller son my\u00e9lome indolent &#8211; un pr\u00e9curseur du my\u00e9lome multiple, un cancer du sang rare affectant les plasmocytes.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Il s&rsquo;y rendait quelques fois par ann\u00e9e depuis plus de dix ans. Mais cette fois-ci, il se souvient que son m\u00e9decin lui a dit : \u00ab Tout a chang\u00e9 \u00bb.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">[&#8230;]<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Depuis le d\u00e9but de son traitement, M. Hussey dit avoir rencontr\u00e9 des obstacles pour acc\u00e9der aux m\u00e9dicaments dont il avait besoin; un probl\u00e8me qui, selon lui, n&rsquo;est que trop courant chez les personnes atteintes de cancer au Canada.Les longs d\u00e9lais d&rsquo;approbation des m\u00e9dicaments signifient que de nombreuses personnes meurent en attendant des m\u00e9dicaments qui sont facilement disponibles dans d&rsquo;autres pays d\u00e9velopp\u00e9s.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.cbc.ca\/news\/canada\/ottawa\/long-wait-for-cancer-drug-approvals-causing-great-anguish-among-patients-doctors-1.7431786\"><strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-blue-color\">Lire l&rsquo;article complet sur CBC News (en anglais)&nbsp;<\/mark><\/strong><\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/nationalpost.com\/diseases-and-conditions\/cancer\/barriers-to-cancer-treatment-in-canada-are-leaving-patients-and-doctors-struggling-for-solutions\"><strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-blue-color\">Lire l&rsquo;article sur National Post (en anglais)<\/mark><\/strong><\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Des traitements potentiellement vitaux retard\u00e9s par la bureaucratie, selon les m\u00e9decins En avril 2017, Glenn Hussey s&rsquo;est rendu \u00e0 l&rsquo;H\u00f4pital d&rsquo;Ottawa pour un examen r\u00e9gulier afin de surveiller son my\u00e9lome indolent &#8211; un pr\u00e9curseur du my\u00e9lome multiple, un cancer du sang rare affectant les plasmocytes. Il s&rsquo;y rendait quelques fois par ann\u00e9e depuis plus de [&hellip;]<\/p>\n","protected":false},"author":10,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[88,53],"tags":[],"class_list":["post-29944","post","type-post","status-publish","format-standard","hentry","category-actualites","category-actualites-et-evenement"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/29944","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/comments?post=29944"}],"version-history":[{"count":3,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/29944\/revisions"}],"predecessor-version":[{"id":29951,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/29944\/revisions\/29951"}],"wp:attachment":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/media?parent=29944"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/categories?post=29944"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/tags?post=29944"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}